Four cancer cases with pathological germline variant RAD51D c.270_271dup
Journal of Obstetrics and Gynaecology Research · 2024
DOI: 10.1111/jog.16045 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Eiko Ishihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Germ-Line Mutation. Die Arbeit nennt 15 Literaturangaben. Gefördert von: This research was supported by AMED.
Abstract (Originalsprache)
Pathological germline variants (PGVs) of RAD51D increase the risk of breast and ovarian cancer. In East Asia, c.270_271dup is the most frequently detected PGV of RAD51D ; however, only a few cases have been reported in Japan. We report four cancer cases with a germline RAD51D c.270_271dup PGV. Three of them (lung cancer: 2, oral cancer: 1) were incidentally identified by whole genome sequencing in patients negative for the associated cancer histories, homologous recombination (HR) deficiency, or a second hit of RAD51D in the cancer DNA. For genetic counseling, we provided information on surveillance and cascade testing based on Western guidelines. The PGVs of moderate‐risk HR‐related genes are difficult to detect based on phenotype, especially in male‐predominant pedigrees. The current spread of cancer genomic analysis will increase opportunities for incidental variant identification. The establishment of Japanese guidelines is expected to aid in the management of PGV carriers of moderate‐risk genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetic Medicine Promotion, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Breast Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Respiratory Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
- Division of Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.
ORCID-Profile: Hiroyuki Matsubayashi
Förderung
- This research was supported by AMED
Zitieren
APA
Ishihara, E., Matsubayashi, H., Nishimura, S., Isaka, M., Konno, H., Goto, S., Yamaguchi, K., & Urakami, K. (2024). Four cancer cases with pathological germline variant RAD51D c.270_271dup. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.16045
Vancouver
Ishihara E, Matsubayashi H, Nishimura S, Isaka M, Konno H, Goto S, et al. Four cancer cases with pathological germline variant RAD51D c.270_271dup. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.16045
BibTeX
@article{Ishihara2024,
author = {Ishihara, Eiko and Matsubayashi, Hiroyuki and Nishimura, Seiichiro and Isaka, Mitsuhiro and Konno, Hayato and Goto, Seiya and Yamaguchi, Ken and Urakami, Kenichi},
title = {Four cancer cases with pathological germline variant RAD51D c.270_271dup},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
doi = {10.1111/jog.16045}
}
EUVIMED